Noveris Health Sciences Inc.
MYCOF
Rank in Stocks
#23287
Noveris Health Sciences Inc. operates as a biotechnology firm dedicated to the... Noveris Health Sciences Inc. operates as a biotechnology firm dedicated to the investigation, pharmaceutical development, and clinical evaluation of psilocybin-based products. Co-founded by Parente Carman, Damon Michaels, and Robert Roscow on September 27, 2013, the company maintains its headquarters in Vancouver, Canada.
Share Price
$0.73
Last synced: 2026-11-16
Market Cap
$42.74M
Change (1 day)
0.00%
Change (1 year)
660.42%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Noveris Health Sciences Inc. (MYCOF)
Category
Healthcare
Operating Margin for Noveris Health Sciences Inc. (MYCOF)
Operating Margin as of November 2026 TTM: 0.00%
According to Noveris Health Sciences Inc.'s latest financial reports, its current operating margin (TTM) is 0.00%. At the end of 2024 the company had an operating margin of 0.00%.
Operating Margin history for Noveris Health Sciences Inc. from 2013 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 0.00% | 0.00% |
| 2024 | 0.00% | 0.00% |
| 2023 | 0.00% | 0.00% |
| 2022 | 0.00% | -100.00% |
| 2021 | -294,931.03% | -31.13% |
| 2020 | -428,262.51% | 16,108.31% |
| 2019 | -2,642.24% | -5.39% |
| 2018 | -2,792.73% | 0.00% |
| 2017 | 0.00% | 0.00% |
| 2016 | 0.00% | -100.00% |
| 2015 | 4,430.54% | 235.48% |
| 2014 | 1,320.65% | 2,578.26% |
| 2013 | 49.31% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 59.80% | - |
US
|
|
| 31.60% | - |
SE
|
|
| 30.13% | - |
FR
|
|
| 29.76% | - |
HK
|
|
| 31.11% | - |
IT
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Noveris Health Sciences Inc.'s operating margin
What was Noveris Health Sciences Inc.'s operating margin in 2024?
In 2024, Noveris Health Sciences Inc.'s operating margin was 0.00%, compared with 0.00% in 2023.
How has Noveris Health Sciences Inc.'s operating margin changed since 2019?
From 2019 to 2024, Noveris Health Sciences Inc.'s operating margin was highest in 2024 (0.00%) and lowest in 2020 (-428,262.51%).
How does Noveris Health Sciences Inc.'s operating margin compare with similar companies?
Noveris Health Sciences Inc.'s operating margin (0.00%) is lower than that of all 5 similar companies listed above. The highest among them is Royalty Pharma plc, with 59.80%.